Latest Posts

Last night, the winners of the 2018 MS MasterClass intermodule delegate projects were announced. Dr Rachel Dorsey-Campbell was voted winner by her peer group and faculty for implementing a pharmacy-led prescribing and monitoring service for natalizumab. Her research found that the new service resulted in better monitoring of patient health when being treated, making the […]

Following the successful completion of a quality improvement pilot in orthopaedic surgery entitled Getting It Right First Time (GIRFT), the Department of Health and NHS Improvement (NHSI) have commissioned an expansion of the GIRFT programme that will cover an additional 35 clinical areas over four years from April 2017 to support providers in delivering clinical […]

We are delighted to announce that Dr Bindu Yoga, an MS MasterClass graduate, has recently had a poster selected by the Association of British Neurologists (ABN) for her work on timely access to disease-modifying treatments (DMTs) in multiple sclerosis (MS). Current guidelines say treatment should start ‘as soon as possible’ after a decision is made, […]

The Neurology Academy hosted a debate at the ABN conference this year to discuss the newly proposed NHS England algorithm for using disease-modifying treatments (DMTs) to manage multiple sclerosis (MS). We interviewed a number of key people at the debate on 9th May to help get a clearer and fuller picture of what this algorithm […]

You may have heard about the EU’s new privacy law General Data Protection Regulation (GDPR). Sarah Gillett, the Neurology Academy’s Managing Director, has been talking to Toby Foster this morning on BBC Radio Sheffield about what the Academy does to comply with upcoming legislation. You can listen to the interview about the GDPR here. (Source: BBC […]

You may be aware of the new ‘Recommendations for an NHS England algorithm to use disease-modifying drugs to treat Multiple Sclerosis’ is currently out for public consultation. The algorithm raises several issues for clinical practice. We are hosting an evening dinner in the ICC where the Association of British Neurologists (ABN) is being held, on […]

I am really delighted to be appointed Honorary Strategic Director for the Multiple Sclerosis Academy. I wanted to take this opportunity to talk about the Academy and some of the plans that we have for the next few years. From my first involvement at the pilot stage of the first Masterclass it was clear that […]

Dr Paul Gallagher and Dr Sarah-Jane Martin from the Institute of Neurological Sciences in Glasgow undertook their MS Masterclass project to understand if patients in their Centre on Fingolimod were adequately screened for macular oedema. Fingolimod is a first in class sphingosine-1 phosphate (S1P) receptor modulator and was the first oral DMT licensed for use […]

Chris is 32 years old and has relapsing-remitting multiple sclerosis (MS). He lives in Cornwall with his wife and their young child. He started alemtuzumab in 2015, with a second round in 2016 – but following a relapse in 2017, he was faced with a choice of either a third round, or a request to […]

We are delighted to announce that this year’s MasterClass Project Award winner is Dr Francisco Javier Carod Artal for his epidemiological study of MS in the Highlands region of Scotland. The MasterClass project is an integral part of the course which attendees undertake on a subject of interest within their own work setting. Dr Artal decided […]